摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-amino-hexan-1-ol | 344240-78-4

中文名称
——
中文别名
——
英文名称
4-amino-hexan-1-ol
英文别名
4-Aminohexan-1-ol
4-amino-hexan-1-ol化学式
CAS
344240-78-4
化学式
C6H15NO
mdl
——
分子量
117.191
InChiKey
MPEIIIWBVXISKP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    8
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    46.2
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl 3-(1-(2,6-difluorobenzyl)-6-(4-(((methoxyamino)carbonyl)amino)phenyl)-5-((methyl(2-pyridinylmethyl)amino)methyl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)propanate 、 4-amino-hexan-1-ol 以gave the title compound (154 mg, 45%) as colorless crystals的产率得到N-(4-(1-(2,6-difluorobenzyl)-3-(4-hydroxycyclohexyl)-5-((methyl(2-pyridinylmethyl)amino)methyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea
    参考文献:
    名称:
    THIENOPYRIMIDINE COMPOUNDS AND USE THEREOF
    摘要:
    本发明提供了一种化合物,其表示为以下式子:其中,R1是C1-4烷基;R2是(1)一种含氮的5-至7-成员杂环基团,其可以具有从以下组中选择的取代基,包括(1')卤素,(2')羟基,(3')C1-4烷基和(4')C1-4烷氧基,(2)苯基,其可以具有从以下组中选择的取代基,包括(1')卤素,(2')C1-4烷氧基-C1-4烷基,(3')单一C1-4烷基-氨基甲酰-C1-4烷基,(4')C1-4烷氧基和(5')单一C1-4烷基氨基甲酰-C1-4烷氧基等;R3是C1-4烷基;R4是C1-4烷氧基等;n是1至4的整数;或其盐,作为一种具有促性腺激素释放激素拮抗活性的噻唑嘧啶类化合物。
    公开号:
    US20120071486A1
  • 作为产物:
    描述:
    4-硝基己醛乙醇 作用下, 生成 4-amino-hexan-1-ol
    参考文献:
    名称:
    The Reaction of α,β-Unsaturated Aldehydes with Nitro Compounds1,2
    摘要:
    DOI:
    10.1021/ja01124a060
点击查看最新优质反应信息

文献信息

  • Functionallization of the δ-carbon atom by the ferrous ion induced decomposition of alkyl hydroperoxides in the presence of cupric salts
    作者:Z̈ivorad Čeković、Milutin Cvetković
    DOI:10.1016/s0040-4039(00)87708-4
    日期:1982.1
    In the ferrous ion induced decomposition of alkyl hydroperoxides in the presence of cupric halides or pseudohalides, intramolecular functionalization, with ligand transfer from cupric salts to δ-carbon atom, is achieved.
    在亚铜离子在卤化铜或假卤化物的存在下诱导的烷基氢过氧化物的分解中,实现了分子内功能化,配体从铜盐转移到δ-碳原子。
  • SUBSTITUTED OXAZOLIDINONES AND THEIR USE
    申请人:Allerheiligen Swen
    公开号:US20100184740A1
    公开(公告)日:2010-07-22
    The invention relates to novel substituted oxazolidinones, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of thromboembolic disorders.
    该发明涉及新型取代氧唑啉酮,其制备方法,其用于治疗和/或预防疾病以及用于制备治疗和/或预防疾病的药物,特别是血栓栓塞性疾病。
  • [EN] BET BROMODOMAIN INHIBITORS AND THERAPEUTIC METHODS USING THE SAME<br/>[FR] INHIBITEURS DE BROMODOMAINES BET ET MÉTHODES THÉRAPEUTIQUES LES UTILISANT
    申请人:UNIV MICHIGAN
    公开号:WO2014164596A1
    公开(公告)日:2014-10-09
    Inhibitors of BET bromodomains and compositions containing the same are disclosed. Methods of using the BET bromodomain inhibitors in the treatment of diseases and conditions wherein inhibition of BET bromodomain provides a benefit, like cancers, also are disclosed.
    本文披露了BET bromodomain抑制剂及含有它们的组合物。还披露了使用BET bromodomain抑制剂治疗疾病和状况的方法,其中BET bromodomain的抑制提供益处,如癌症等疾病。
  • THIENOPYRIMIDINE COMPOUNDS AND USE THEREOF
    申请人:TAKEDA PHARMACEUTICAL COMPANY LIMITED
    公开号:US20140221381A1
    公开(公告)日:2014-08-07
    The present invention provides a compound represented by the formula: wherein R 1 is a C 1-4 alkyl; R 2 is (1) a 5- to 7-membered nitrogen-containing heterocyclic group which may have a substituent selected from the group consisting of (1′) a halogen, (2′) a hydroxy group, (3′) a C 1-4 alkyl and (4′) a C 1-4 alkoxy, (2) a phenyl which may have a substituent selected from the group consisting of (1′) a halogen, (2′) a C 1-4 alkoxy-C 1-4 alkyl, (3′) a mono-C 1-4 alkyl-carbamoyl-C 1-4 alkyl, (4′) a C 1-4 alkoxy and (5′) a mono-C 1-4 alkylcarbamoyl-C 1-4 alkoxy, or the like; R 3 is a C 1-4 alkyl; R 4 is a C 1-4 alkoxy, or the like; n is an integer of 1 to 4; or a salt thereof, as a thienopyrimidine compound having gonadotropin-releasing hormone antagonistic activity.
    本发明提供了一种化合物,其表示为式:其中,R1是C1-4烷基;R2是(1)含氮的5-7元杂环基团,该基团可以具有从群组(1')卤素,(2')羟基,(3')C1-4烷基和(4')C1-4烷氧基中选择的取代基,或(2)苯基,该苯基可以具有从群组(1')卤素,(2')C1-4烷氧基-C1-4烷基,(3')单个C1-4烷基-氨基甲酰-C1-4烷基,(4')C1-4烷氧基和(5')单个C1-4烷基-氨基甲酰-C1-4烷氧基等中选择的取代基;R3是C1-4烷基;R4是C1-4烷氧基或类似物;n是1到4的整数;或其盐,作为一种具有促性腺激素释放激素拮抗活性的噻唑嘧啶化合物。
  • Thiazolidinones and the use therof as polo-like kinase inhibitors
    申请人:Schwede Wolfgang
    公开号:US20060079503A1
    公开(公告)日:2006-04-13
    Thiazolidones of general formula I in which R 1 , R 2 , R 3 , X and Y have the meanings that are indicated in the description, their production and use as inhibitors of polo-like kinases (PLK) for treating various diseases as well as intermediate products for the production of thiazolidones are described.
    本文描述了通式I的噻唑烷酮,其中R1、R2、R3、X和Y的含义如描述中所示,它们的生产和用途作为极化样激酶(PLK)的抑制剂,用于治疗各种疾病,以及用于生产噻唑烷酮的中间体。
查看更多